SCHEMBL19854697

SCHEMBL19854697

C=C(CO)C(=O)Oc1cc(OC(=O)C(=C)CO)cc(-c2ccc(-c3ccc(CCC4CCC(CCCCC)CC4)cc3)cc2)c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.36
▸ RARB P10826 9/20 0.35
▸ ITGB3 P05106 4/20 0.35
▸ ITGA2B P08514 4/20 0.35
▸ GPR84 Q9NQS5 1/20 0.35
▸ RARA P10276 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C8 P10632 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ S1PR3 Q99500 1/20 0.34
▸ FFAR4 Q5NUL3 2/20 0.33
▸ RARG P13631 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19854694 0.88 ITGB3 (0.37) RARBITGB3ITGA2BRARAMEN1
SCHEMBL19854418 0.88 CYP2C9 (0.40) MEN1ALDH1A1MAPTKMT2ACYP2C9
SCHEMBL19855547 0.88 CYP2C9 (0.40) MEN1ALDH1A1MAPTKMT2ACYP2C9
SCHEMBL19855382 0.87 PARP15 (0.37) RARBITGB3ITGA2BFFAR4
SCHEMBL19755082 0.86 THRB (0.43) THRBITGB3ITGA2BCYP3A4CYP2C8
SCHEMBL20313538 0.86 KMT2A (0.35) MEN1MAPTKMT2ACYP2D6CYP2C9
SCHEMBL19722301 0.86 RARB (0.42) THRBRARBRARAS1PR3FFAR4
SCHEMBL20313515 0.86 THRB (0.48) THRBRARBRARAMEN1ALDH1A1
SCHEMBL20313480 0.86 THRB (0.48) THRBRARBRARAMEN1ALDH1A1
SCHEMBL19855545 0.86 THRB (0.48) THRBRARBRARAMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-06-28 — — US disclosed
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-06-28 — — US disclosed
WO-2018025974-A1 LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE JNC株式会社 2018-02-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE C1S, CCND1, C5 THRB 4469/4885RARB 3791/4885ITGB3 2671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback